CLIFTON PARK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ZEBRAFISH DISEASE MODELS SOCIETY, founded in 2014, is a small nonprofit in the Medical Research sector that reported $255K in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $48K, a strong 19% operating margin.
ZEBRAFISH DISEASE MODELS SOCIETY AIMS TO ACT AS A MEETING POINT FOR ACADEMIC, CLINICAL AND INDUSTRIAL SCIENTISTS USING ZEBRAFISH DISEASE MODELS AND TO SUPPORT AND FOSTER KNOWLEDGE GENERATION, DISCUSSION, TRAINING AND EDUCATION ABOUT ZEBRAFISH DISEASE MODELS BY PROMOTING THE STUDY, RESEARCH AND USE OF ZEBRAFISH DISEASE MODELS THROUGHOUT THE WORLD, DIVERSITY AMONG THE ZEBRAFISH COMMUNITY, PUBLIC AWARENESS OF THE IMPORTANCE OF THE FIELD, AND OFFER INFORMED OPINIONS ON ZEBRAFISH DISEASE MODELS.
IN 2024, THE SOCIETY ORGANIZED THE ZEBRAFISH DISEASE MODELS 17TH CONFERENCE HELD IN LISBON, PORTUGAL. ZDM17 CONFERENCE BROUGHT IN A TOTAL OF 299 CONFIRMED ATTENDEES IN-PERSON. THE SOCIETY HELD A...
IN 2024, THE SOCIETY ORGANIZED THE ZEBRAFISH DISEASE MODELS 17TH CONFERENCE HELD IN LISBON, PORTUGAL. ZDM17 CONFERENCE BROUGHT IN A TOTAL OF 299 CONFIRMED ATTENDEES IN-PERSON. THE SOCIETY HELD A TOTAL OF 12 VIRTUAL MEETINGS FROM FEBRUARY THROUGH SEPTEMBER OF 2024. OVER 700 PEOPLE REGISTERED TO ATTEND THESE VIRTUAL EVENTS TO PROMOTE THE STUDY, RESEARCH, AND USE OF ZEBRAFISH DISEASE MODELS THROUGHOUT THE WORLD. APPROXIMATELY 417 PEOPLE ATTENDED THESE VIRTUAL EVENTS. THE SOCIETY ESTABLISHED ELEVEN RESEARCH INTEREST GROUPS AND ALSO HELD TWO EARLY CAREER INVESTIGATOR VIRTUAL SESSIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $254,924 | $194,218 | +0.3% |
| Expenses | $206,862 | $238,609 | -0.1% |
| Net Income | $48,062 | $-44,391 | -2.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MARINA MIONE | PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| TERESA BOWMAN | VICE PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| ANNEMARIE MEIJER | SECRETARY | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| TRISTA NORTH | TREASURER | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| KAZUHIDE ASAKAWA | DIRECTOR (THRU OCT) | 1.00 |
Director
|
$0 | $0 | $0 |
| BON-CHU CHUNG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREW COX | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HUI FENG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| YI FENG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RITA FIOR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MIGUEL GODHINO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARY GOLL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRIS HALL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GENEVIEVE KENDALL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SOFIA DE OLIVEIRA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CARINE SMITH | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID TOBIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| EIRINI TROMPOUKI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VALERIE WITTAMER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $254,924 | $206,862 | $254,379 | $48,062 |
| 2023 | $194,218 | $238,609 | $204,561 | $-44,391 |
| 2022 | $213,629 | $247,938 | $244,609 | $-34,309 |
| 2020 | $29,591 | $74,343 | $262,570 | $-44,752 |
| 2019 | $282,760 | $200,232 | $310,174 | $82,528 |
| 2018 | $278,891 | $215,803 | $240,147 | $63,088 |
Compare ZEBRAFISH DISEASE MODELS SOCIETY with other nonprofits in New York and across the country.